|Articles|January 11, 2019

Update on the ELIANA trial (VIDEO)

For Contemporary Pediatrics, Dr Bobby Lazzara discusses the latest data on the effectiveness of CAR T-cell therapy from the ELIANA trial, which was presented at the 2018 American Society of Hematology annual meeting in San Diego, California.

For Contemporary Pediatrics, Dr Bobby Lazzara discusses the latest data on the effectiveness of CAR T-cell therapy from the ELIANA trial, which was presented at the 2018 American Society of Hematology annual meeting in San Diego, California.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Subscribe

Related Content

Eczema, delayed allergen introduction, and early antibiotics top list of childhood food allergy risk factors | Image Credit: © monticellllo - stock.adobe.com.

Latest CME

Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Update on the ELIANA trial (VIDEO)

Related Content

Eczema, delayed allergen introduction, and early antibiotics top list of childhood food allergy risk factors

Study: Breast milk and infant gut microbiota shift over first 8 postpartum weeks

Closing the Pediatric AD Referral Gap: What Specialists Need to See

What Pediatricians Should Know About JAK Inhibitors Before Referral

Nonsteroidal topical therapies expand treatment options for pediatric skin conditions